Myocarditis risk after mRNA COVID-19 vaccination

What peer‑reviewed evidence exists about myocarditis risk after mRNA COVID-19 vaccines, and how does that risk compare to infection?

Peer‑reviewed systematic reviews, population cohort studies and clinical reviews consistently find that is a rare event concentrated in younger males, usually after the second dose, and that myocardit...